|
Device Panelists’ Trial Critiques Are Killing Companies, Critics Say
Device innovation is suffering because FDA conflict of interest rules keep experienced and insightful practitioners from serving on advisory panels, industry and lawmakers say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives